Pathological changes of placenta in thrombophilia during pregnancy

doi:10.3877/cma.j.issn.2095-3259.2014.02.003

Abstract

Abstract:

This paper describes the mechanism of the placenta circulatory disturbance of thrombophilia in pregnancy, and investigates the pathologic patterns of placentas through both sides of the maternal blood circulation disorders and uterine blood circulation disorders. This paper attempt to add deeper understanding of thrombophilia and recognize the pathological mechanism of relevant perinatal outcomes.

Key words: Thrombophilia, Pregnancy complications, Placenta, Pathologic processes

Jing He, Lu Chen. Pathological changes of placenta in thrombophilia during pregnancy[J]. Chinese Journal of Obstetric Emergency(Electronic Edition), 2014, 03(02): 86-89.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhckjjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3259.2014.02.003

https://zhckjjdzzz.cma-cmc.com.cn/EN/Y2014/V03/I02/86

References 15

[1]	College of American Pathologists Consensus Conference XXXVI: Diagnostic Issues in Thrombophilia[J]. Arch Pathol Lab Med, 2002, 126(11):1277-1433.
[2]	Carraro P. Guidelines for the laboratory investigation of inherited thrombophilias. Recommendations for the first level clinical laboratories[J]. Clin Chem Lab Med, 2003, 41(3):382-391.
[3]	Rodger MA. An update on thrombophilia and placenta mediated pregnancy complications: what should we tell our patients? [J]. Thromb Res, 2013, 131 Suppl 1:S25-S27.
[4]	Khalafallah AA, Ibraheem AR, Teo QY, et al. Review of management and outcomes in women with thrombophilia risk during pregnancy at a single institution[J]. ISRN Obstet Gynecol, 2014:381826.
[5]	Rodger MA, Walker MC, Smith GN, et al. Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study[J]. J Thromb Haemost, 2014, 12(4):469-478
[6]	Bremme KA. Hemostatic changes in pregnancy[J]. Ballieres Best Pract Res Clin Hameatol, 2003, 16(2): 153-168.
[7]	Issermann B, Sood R, Pawl1nski R, et a1. The thrombomodulin-protein C system is essential for the maintenance of pregnancy[J]. Nat Med, 2003, 9(3):331-337.
[8]	Mäkikallio K1, Tekay A, Jouppila P. Effects of bleeding on uteroplacental, umbilicoplacental and yolk-sac hemodynamics in early pregnancy[J]. Ultrasound Obstet Gynecol, 2001, 18(4):352-356.
[9]	Many A, Schreiber L, Rosner S, et al. Pathologic features of the placenta in women with severe pregnancy complications and thrombophilia[J]. Obstet Gynecol, 2001, 98(6):1041-1044.
[10]	张为远. 中华围产医学[M]. 北京：人民卫生出版社，2012: 471-472.
[11]	Ghidini A, Salafia CM, Pezzullo JC. Placental vascular lesions and likelihood of diagnosis of preeclampsia[J]. Obstet Gynecol, 1997, 90(4 Pt 1):542-545.
[12]	Boisramé T, Sananès N, Fritz G, et al. Placental abruption: risk factors, management and maternal-fetal prognosis. Cohort study over 10 years[J]. Eur J Obstet Gynecol Reprod Biol, 2014, 179:100-104.
[13]	刘伯宁. 妊娠期易栓症的胎盘病理[J]. 实用妇产科杂志，2009, 3(25):132-134.
[14]	Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta[J]. J Matern Fetal Med, 1998, 7(6):277-286.
[15]	Lepais L, Gaillot-Durand L, Boutitie F, et al. Fetal thrombotic vasculopathy is associated with thromboembolic events and adverse perinatal outcome but not with neurologic complications: A retrospective cohort study of 54 cases with a 3-year follow-up of children[J]. Placenta, 2014, pii: S0143-4004(14)：164-167.

Please choose a citation manager

Content to export